| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |